Clinical trial
A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic…
NCT00340314 · IRCCS San Raffaele, Other · Completed
Key facts
| NCT number | NCT00340314 |
|---|---|
| Title | A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF) |
| Official title | A Controlled Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Treating Paroxysmal Atrial Fibrillation. The Ablation for Paroxysmal Atrial Fibrillation (APAF2) Trial |
| Acronym | APAF2 |
| Lead sponsor | IRCCS San Raffaele, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug, Procedure |
| Interventions | Circumferential Pulmonary Vein Ablation, Antiarrhythmic Drug Therapy |
| Enrollment | 198 |
| Start date | Jan 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 28, 2010 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: